SCHEMBL25063290

SCHEMBL25063290

CC(=O)Nc1ccccc1C(=O)Oc1ccc(C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ HPGD P15428 5/20 0.57
▸ ALDH1A1 P00352 7/20 0.56
▸ KDM4E B2RXH2 6/20 0.56
▸ GLA P06280 1/20 0.56
▸ PTK2B Q14289 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ CYP2C19 P33261 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ LMNA P02545 4/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ MAPT P10636 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13777318 0.89 CYP2C19 (0.60) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL25063444 0.87 SMN1; SMN2 (0.58) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL25063289 0.87 HPGD (0.56) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL25063171 0.87 HPGD (0.56) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL10803154 0.84 HPGD (0.52) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL208281 0.82 PTK2B (0.70) HSD17B10ALOX15HPGDALDH1A1KDM4E
SCHEMBL8104888 0.81 PTK2B (0.54) HSD17B10HPGDALDH1A1KDM4EPTK2B
SCHEMBL11775186 0.80 HSD17B10 (0.53) HSD17B10ALOX15MAPK1HPGDALDH1A1
SCHEMBL10983921 0.79 PTK2B (0.66) HSD17B10ALOX15HPGDALDH1A1KDM4E
SCHEMBL1640485 0.79 KMT2A (0.71) HSD17B10ALOX15MAPK1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 HSD17B10 2241/4885ALOX15 4242/4885MAPK1 2729/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 HSD17B10 2241/4885ALOX15 4242/4885MAPK1 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback